Clinical Trial Update: Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether preoperative iron isomaltoside 1000 improves hemoglobin in patients undergoing transcatheter aortic valve implantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• Iron isomaltoside 1000 (iron isomaltoside 1000)

Snippet

Sponsor: Yonsei University | Conditions: Aortic Stenosis (Treated With TAVI) | Phase 4 | Status: UNKNOWN